SRx Health Solutions' compliance plan with NYSE is accepted, extending its listing until July 14, 2026.
Quiver AI Summary
SRx Health Solutions, Inc. has announced that the New York Stock Exchange has accepted its plan to regain compliance with listing standards after the company fell below the required stockholders’ equity of $4 million due to reported losses. This compliance plan follows a notification from the NYSE on October 14, 2025, and allows the company to maintain its listing with a targeted completion date of July 14, 2026. During this period, SRx will provide quarterly updates to the NYSE on its progress. The press release also includes forward-looking statements that highlight potential risks and uncertainties regarding future performance and compliance efforts.
Potential Positives
- The NYSE's acceptance of SRx Health Solutions' plan to regain compliance indicates that the company has a viable strategy to address its financial issues and continue its listing on the exchange.
- The extension provided by the NYSE allows the company additional time to improve its financial standing and meet compliance standards, demonstrating a commitment to recovery.
- SRx Health Solutions will provide quarterly updates to the NYSE during the plan period, which increases transparency and builds investor confidence in the company's efforts to resolve its financial challenges.
Potential Negatives
- The company is on notice for falling below the NYSE's continued listing standard, raising concerns about its financial stability.
- There is a limited timeframe (until July 14, 2026) to regain compliance, which adds pressure on the company's performance.
- The need to provide quarterly updates on progress could indicate ongoing operational challenges, potentially affecting investor confidence.
FAQ
What compliance plan did SRx Health Solutions announce?
SRx Health Solutions announced that the NYSE accepted its plan to regain compliance with listing standards requiring stockholders’ equity of $4 million or more.
What is the deadline for SRx Health Solutions' compliance plan?
The targeted completion date for the compliance plan is July 14, 2026.
What notification did SRx Health Solutions receive from the NYSE?
On October 14, 2025, the NYSE notified SRx Health Solutions that it had fallen below the required stockholders' equity standard.
How will SRx Health Solutions update the NYSE during the plan period?
The company will provide quarterly updates to the NYSE American on its progress regarding the compliance plan's goals and initiatives.
What risks does SRx Health Solutions face with its forward-looking statements?
Risks include the ability to complete proposed transactions, shareholder approvals, market conditions, and regulatory considerations, among others.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SRXH Revenue
$SRXH had revenues of $-38.9M in Q4 2025. This is an increase of 272.97% from the same period in the prior year.
You can track SRXH financials on Quiver Quantitative's SRXH stock page.
$SRXH Hedge Fund Activity
We have seen 7 institutional investors add shares of $SRXH stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 156,724 shares (+inf%) to their portfolio in Q3 2025, for an estimated $49,681
- GEODE CAPITAL MANAGEMENT, LLC added 42,993 shares (+146.7%) to their portfolio in Q3 2025, for an estimated $13,628
- ALTIUM CAPITAL MANAGEMENT LLC removed 38,984 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,357
- HRT FINANCIAL LP removed 28,782 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,123
- VIRTU FINANCIAL LLC added 24,146 shares (+149.6%) to their portfolio in Q3 2025, for an estimated $7,654
- JANE STREET GROUP, LLC added 22,774 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,219
- FNY INVESTMENT ADVISERS, LLC removed 17,573 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,570
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NORTH PALM BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that the New York Stock Exchange (“NYSE”) has accepted the Company’s plan to regain compliance with the continued listing standards in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
As previously disclosed, NYSE notified the Company on October 14, 2025 that the Company had fallen below the NYSE’s continued listing standard requiring a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. With the NYSE’s acceptance of the Company’s plan to regain compliance, the Company’s listing is being continued pursuant to an extension with a targeted completion date of July 14, 2026 (the “Plan Period”). The Company will provide quarterly updates to the NYSE American during the Plan Period on its progress with the goals and initiatives outlined in the plan.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
[email protected]
Media Contact
KCSA Strategic Communications
Kristin Cwalinski, Senior Vice President
[email protected]
